Delivery Order SPE2DR25D3005-SPE2DR26FP7VD
- Not listed
- The Defense Logistics Agency awarded a $8,690.90 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle, leveraging the company's established relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $18,854.38 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units) with an ultimate completion date of December 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $3,752.08 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 9, 2025, and represents a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $5,764.40, with completion expected by November 21, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $6,097.91. This non-competitive delivery order is expected to be completed by August 26, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $3,757.66 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location and an ultimate completion date of December 9, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $6,924.92 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a completion date of July 30, 2025. This non-competitive, firm fixed-price delivery order represents a pediatric or routine pharmaceutical resupply requirement under the company's existing contract vehicle with DLA. The order will be fulfilled from AmerisourceBergen's distribution operations in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $10,998.10 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025, and will be performed at the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens valued at $8,501.80. This delivery order represents a firm fixed price contract with a completion date of August 12, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7VDDelivery Order
The Defense Logistics Agency awarded a $11,848.69 delivery order to AmerisourceBergen Drug Corp on December 7, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle, which enables supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company's federal contract portfolio demonstrates extensive experience fulfilling competitive federal medical supply requirements across multiple therapeutic domains, including specialty medications and injectable pharmaceuticals like Mounjaro, which is used in diabetes and weight management treatment. This award reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and broader military healthcare systems through the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 12/6/25 |